Search research articles
Contact Us
Filters
Showing results (121-130 of 136) with videos related to
Page
of 14
Sort By:
Biochemical Pharmacology
|
January 20, 1994
Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro
T S Lin, M Z Luo, M C Liu, et al.
Clinical and Translational Science
|
February 5, 2017
Performance of Redox Active and Chelatable Iron Assays to Determine Labile Iron Release From Intravenous Iron Formulations
A B Pai, D E Meyer, B C Bales, et al.
Antisense & Nucleic Acid Drug Development
|
August 6, 1999
Increased potency of an aptameric G-rich oligonucleotide is associated with novel functional properties of phosphorothioate linkages
R C Tam, S Wu-Pong, B Pai, et al.
Journal of Medicinal Chemistry
|
August 4, 1995
Anti-AIDS (acquired immune deficiency syndrome) agents. 17. New brominated hexahydroxybiphenyl derivatives as potent anti-HIV agents
L Xie, J X Xie, Y Kashiwada, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1997
Inhibition of replication of hepatitis B virus by cytallene in vitro
Y L Zhu, S B Pai, S H Liu, et al.
Antiviral Chemistry & Chemotherapy
|
July 12, 2005
Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosides
S Balakrishna Pai, Rekha B Pai, Meng-yu Xie, et al.
Hematology/Oncology and Stem Cell Therapy
|
June 26, 2023
Peritoneal and Pleural Drains in Pediatric Hematopoietic Cell Transplant Recipients with Veno-Occlusive Disease are Safe and Do Not Adversely Impact Clinical Outcomes
Hemalatha G Rangarajan, Vinita B Pai, Joseph R Stanek, et al.
International Journal of Dermatology
|
April 7, 1999
Quantitative estimation and recommendations for supplementation of protein lost through scaling in exfoliative dermatitis
G R Kanthraj, C R Srinivas, P U Devi, et al.
Antimicrobial Agents and Chemotherapy
|
June 28, 2005
Emergence of a novel mutation in the FLLA region of hepatitis B virus during lamivudine therapy
S Balakrishna Pai, A Mithat Bozdayi, Rekha B Pai, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1995
Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus
C K Chu, T Ma, K Shanmuganathan, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 136) with videos related to
Sort By:
Page
of 14
Biochemical Pharmacology
|
January 20, 1994
Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro
T S Lin, M Z Luo, M C Liu, et al.
Clinical and Translational Science
|
February 5, 2017
Performance of Redox Active and Chelatable Iron Assays to Determine Labile Iron Release From Intravenous Iron Formulations
A B Pai, D E Meyer, B C Bales, et al.
Antisense & Nucleic Acid Drug Development
|
August 6, 1999
Increased potency of an aptameric G-rich oligonucleotide is associated with novel functional properties of phosphorothioate linkages
R C Tam, S Wu-Pong, B Pai, et al.
Journal of Medicinal Chemistry
|
August 4, 1995
Anti-AIDS (acquired immune deficiency syndrome) agents. 17. New brominated hexahydroxybiphenyl derivatives as potent anti-HIV agents
L Xie, J X Xie, Y Kashiwada, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1997
Inhibition of replication of hepatitis B virus by cytallene in vitro
Y L Zhu, S B Pai, S H Liu, et al.
Antiviral Chemistry & Chemotherapy
|
July 12, 2005
Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosides
S Balakrishna Pai, Rekha B Pai, Meng-yu Xie, et al.
Hematology/Oncology and Stem Cell Therapy
|
June 26, 2023
Peritoneal and Pleural Drains in Pediatric Hematopoietic Cell Transplant Recipients with Veno-Occlusive Disease are Safe and Do Not Adversely Impact Clinical Outcomes
Hemalatha G Rangarajan, Vinita B Pai, Joseph R Stanek, et al.
International Journal of Dermatology
|
April 7, 1999
Quantitative estimation and recommendations for supplementation of protein lost through scaling in exfoliative dermatitis
G R Kanthraj, C R Srinivas, P U Devi, et al.
Antimicrobial Agents and Chemotherapy
|
June 28, 2005
Emergence of a novel mutation in the FLLA region of hepatitis B virus during lamivudine therapy
S Balakrishna Pai, A Mithat Bozdayi, Rekha B Pai, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1995
Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus
C K Chu, T Ma, K Shanmuganathan, et al.
Page
of 14